Clinical Trial Update: Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy [Phase 2]

View source ↗

Summary

This report covers safety and effects from a Phase 2 trial of brimonidine implanted intravitreally in patients with glaucomatous optic neuropathy; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucomatous Optic Neuropathy
• Open-angle Glaucoma

Drugs mentioned

• Brimonidine intravitreal implant (brimonidine)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle | Phase 2 | Status: COMPLETED | Results posted: 2013-04-24